BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/7/2025 8:02:54 AM | Browse: 290 | Download: 494
 |
Received |
|
2025-04-29 03:55 |
|
Peer-Review Started |
|
2025-04-29 03:55 |
|
First Decision by Editorial Office Director |
|
2025-05-17 07:55 |
|
Return for Revision |
|
2025-05-17 07:55 |
|
Revised |
|
2025-05-26 12:52 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-21 03:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-22 01:41 |
|
Articles in Press |
|
2025-07-22 01:41 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-04 02:20 |
|
Publish the Manuscript Online |
|
2025-08-07 07:38 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Splenic histiocytic sarcoma: Disease progression from the perspective of pathophysiology
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Meng-Ting Yao, Tao Wang, Hao Luo, Meng-Yuan Yao, Kai Chen and Yong-Qiang Zhu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Program of General Hospital of Western Theater |
No. 2021-XZYG-C33 |
|
| Corresponding Author |
Tao Wang, MD, General Surgery Center, General Hospital of Western Theater Command, No. 270 Rongdu Road, Chengdu 610083, Sichuan Province, China. wangtao301020@sina.com |
| Key Words |
Splenic histiocytic sarcoma; Hemophagocytic syndrome; Pathophysiology; Disease progression; Therapy |
| Core Tip |
Splenic histiocytic sarcoma (SHS) is an exceedingly rare malignant tumor of the spleen. Owing to its low incidence rate and a relatively limited number of clinical cases, the medical community's comprehension of SHS remains in a phase of continuous exploration and refinement. Currently, the pathophysiological process of SHS has not been fully elucidated. A comprehensive clarification of the pathophysiological process of SHS and an in-depth understanding of its pathogenesis are fundamental for the development of effective treatment strategies. |
| Publish Date |
2025-08-07 07:38 |
| Citation |
Yao MT, Wang T, Luo H, Yao MY, Chen K, Zhu YQ. Splenic histiocytic sarcoma: Disease progression from the perspective of pathophysiology. World J Clin Cases 2025; 13(28): 109077 |
| URL |
https://www.wjgnet.com/2307-8960/full/v13/i28/109077.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v13.i28.109077 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
